Serial Number | 97518230 |
Word Mark | ORCHESTRATING THE IMMUNE SYSTEM |
Filing Date | Monday, July 25, 2022 |
Status | 733 - FOURTH EXTENSION - GRANTED |
Status Date | Tuesday, September 9, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, September 5, 2023 |
Goods and Services | Pharmaceutical products and preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, infectious diseases and disorders, cancer, and gastrointestinal diseases and disorders; biological products, namely, preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; cell therapy products, namely, preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; therapeutic products, namely, preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; pharmaceutical products and preparations for the treatment and prevention diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; biological products, namely, preparations for the treatment and prevention diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; cell therapy products, namely preparations for the treatment and prevention diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; therapeutic and medicinal products, namely, preparations for the treatment and prevention diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; diagnostic biomarker reagents for use in diagnosing, preventing, and treating diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, and cancer; diagnostic agents, preparations, and substances for use in diagnosing, preventing, and treating diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, infectious diseases and disorders, cancer, and gastrointestinal diseases and disorders |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, July 28, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Mozart Therapeutics, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Seattle, WA 98119 |
Party Name | Mozart Therapeutics, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Seattle, WA 98119 |
Event Date | Event Description |
Thursday, July 28, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, July 28, 2022 | NEW APPLICATION ENTERED |
Wednesday, May 10, 2023 | ASSIGNED TO EXAMINER |
Thursday, June 1, 2023 | NON-FINAL ACTION WRITTEN |
Thursday, June 1, 2023 | NON-FINAL ACTION E-MAILED |
Thursday, June 1, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, July 10, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, July 10, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, July 10, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, August 3, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, August 16, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, September 5, 2023 | PUBLISHED FOR OPPOSITION |
Tuesday, September 5, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, October 31, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, March 5, 2024 | SOU TEAS EXTENSION RECEIVED |
Tuesday, March 5, 2024 | SOU EXTENSION 1 GRANTED |
Tuesday, March 5, 2024 | SOU EXTENSION 1 FILED |
Wednesday, March 6, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Wednesday, October 23, 2024 | SOU TEAS EXTENSION RECEIVED |
Wednesday, October 23, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Wednesday, October 23, 2024 | SOU EXTENSION 2 GRANTED |
Wednesday, October 23, 2024 | SOU EXTENSION 2 FILED |
Friday, April 4, 2025 | SOU TEAS EXTENSION RECEIVED |
Friday, April 4, 2025 | SOU EXTENSION 3 FILED |
Saturday, April 5, 2025 | SOU EXTENSION 3 GRANTED |
Saturday, April 5, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, September 9, 2025 | SOU EXTENSION 4 FILED |
Tuesday, September 9, 2025 | SOU TEAS EXTENSION RECEIVED |
Tuesday, September 9, 2025 | SOU EXTENSION 4 GRANTED |